iBio, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell iBio, Inc. and other ETFs, options, and stocks.

About IBIO

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. 

CEO
Martin B. Brenner
CEOMartin B. Brenner
Employees
19
Employees19
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1993
Founded1993
Employees
19
Employees19

IBIO Key Statistics

Market cap
10.27M
Market cap10.27M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
Dividend yield
Average volume
3.21M
Average volume3.21M
High today
$1.10
High today$1.10
Low today
$1.02
Low today$1.02
Open price
$1.06
Open price$1.06
Volume
108.60K
Volume108.60K
52 Week high
$6.89
52 Week high$6.89
52 Week low
$0.6358
52 Week low$0.6358

People also own

Based on the portfolios of people who own IBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.